Injectable Drug Delivery Market by Devices, Diseases - 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Injectable drug delivery market
Injectable Drug Delivery Market: By Devices, Therapeutics & Formulations [Self-Injection Devices (Pen, Needle Free & Auto Injectors) Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders, Liposomes, Microspheres, Others]-Forecast(2013-2018)
Report Code : HCR 0023
Published: 06 January, 2015   No. of pages: 165

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report.

While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 – 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years.

The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 – 2018.

Analyzing the competitive landscape of the global conventional injectable devices market for 2012 IndustryARC is of the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%.
1. Injectable Drug Delivery Market Overview
2. Executive Summary
3. Injectable Drug Delivery Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Injectable Drug Delivery Market Forces
   4.1. Market Drivers
      4.1.1. Inherent Use Case Scenario of IDD Devices With Biologics
      4.1.2. Increase in Global Diabetic Population and Usage of Insulin Pens
      4.1.3. Others
   4.2. Market Constraints
      4.2.1. Infection Risks And Government Laws
      4.2.2. Others
   4.3. Market Challenges
      4.3.1. Higher Manufacturing Standards Needed to Avoid Product Recalls
      4.3.2. Others
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Injectable Drug Delivery Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
6 Global Injectable Drug Delivery – Market By Delivery Devices
   6.1 Market Overview
   6.2 Conventional Injection Devices Market
   6.3 Self-Injection Devices Market
   6.4 Other Injection Devices Market
   6.5 Auto Drug Injecting Devices
      6.5.1 By Drug Loading
           6.5.1.1 Prefilled Auto Injectors
           6.5.1.2 Fillable Auto Injectors
           6.5.1.3 By User Intervention
           6.5.1.4 Automated Auto Injectors
           6.5.1.5 Manual Auto Injectors
           6.5.1.6 By Design
                 6.5.1.6.1. Standard Auto Injectors
                 6.5.1.6.2. Customized Auto Injectors
           6.5.1.7. By Reusability
                 6.5.1.7.1. Disposable Auto Injectors
                 6.5.1.7.2. Reusable Auto Injectors
   6.6 Pen Injectors
      6.6.1 By Product
           6.6.1.1 Single Chamber Pen Injectors
           6.6.1.2 Dual Chamber Pen Injectors
      6.6.2 By Reusability
           6.6.2.1 Disposable Pen Injectors
           6.6.2.2 Reusable Pen Injectors
      6.6.3 By Design
           6.6.3.1 Standardized Pen Injectors
           6.6.3.2 Customized Pen Injectors
   6.7 Needle Free Drug Injection Devices
      6.7.1 By Drug Loading
           6.7.1.1 Prefilled Needle Free Injectors
           6.7.1.2 Fillable Needle Free Injectors
      6.7.2 By Technology
           6.7.2.1 Jet-Based Needle-Free Injectors
           6.7.2.2 Spring-Based Needle-Free Injectors
           6.7.2.3 Laser-Based Needle Free Injectors
           6.7.2.4 Vibration-Based Needle Free Injectors
      6.7.3 By Reusability
           6.7.3.1 Disposable Needle Free Injectors
           6.7.3.2 Reusable Needle Free Injectors
   6.8 Conventional Drug Injection Devices
      6.8.1 By Reusability
           6.8.1.1 Disposable Injection Devices
           6.8.1.2 Reusable Injection Devices
      6.8.2 By Material
           6.8.2.1 Glass Based Injectors
           6.8.2.2 Plastic Based Injectors
      6.8.3 By Drug Loading
           6.8.3.1 Prefilled Injection Devices
           6.8.3.2 Fillable Injection Devices
7 Global Injectable Drug Delivery Market – By Drug Formulations
   7.1 Conventional Drug Delivery Formulations
      7.1.1 Injectable Drug Delivery Formulation Solutions
      7.1.2 Reconstituted Drug Delivery Formulation Solutions
   7.2 Novel Drug Delivery Formulation Solutions
      7.2.1 Liposomal Systems
      7.2.2 Microspheres
      7.2.3 Nanoparticles
      7.2.4 Polymeric Micelles
      7.2.5 Others
8 Global Injectable Drug Delivery Market - By Therapeutic Areas
   8.1 Auto-Immune Diseases
      8.1.1 Multiple Sclerosis
      8.1.2 Rheumatoid Arthritis
      8.1.3 Crohn's Diseases
      8.1.4 Psoriasis
      8.1.5 Others
   8.2 Hormonal Disorders
      8.2.1 Diabetes
      8.2.2 Anemia
      8.2.3 Reproductive Health Diseases
      8.2.4 Osteoporosis
      8.2.5 Growth Hormone Deficiency
      8.2.6 Antithrombotic Therapy
   8.3 Orphan Or Rare Diseases
   8.4 Oncology
   8.5 Others
      8.5.1 Pain Management
      8.5.2 Hepatitis C
      8.5.3 Allergies
      8.5.4 Aesthetic Treatment
9 Global Injectable Drug Delivery Market - Geographical Analysis
   9.1 North America
   9.2 Europe
   9.3 Asia Pacific
   9.4 Rest Of World
10. Injectable Drug Delivery Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Injectable Drug Delivery Market Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
   11.1. Becton Dickinson and Company (BD)
   11.2. Baxter International Inc.
   11.3. Consort Medical PLC
   11.4. Crossject SA
   11.5. Eli Lilly and Company
   11.6. Elcam Medical
   11.7. Novo Nordisk
   11.8. Owen Mumford Ltd
   11.9. Sanofi
   11.10. Schott AG
   11.11. Terumo Corporation
   11.12. Ypsomed Holding AG
   11.13. Others
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
List of Tables :

Table 1. Key Company Products, Conventional Injection Devices Market
Table 2. Key Company Products, Self-Injection Devices Market
Table 3. Key Company Products, Needle Free Injection Devices Market
Table 4. Key Company Products, Auto Injector Devices Market
Table 5. Key Company Products, Pen Injection Devices Market
Table 6. Global Diabetic Cases (Millions) and Prevelance Rates (%), 2011 and 2030
Table 7. Global Injectable Drug Delivery Devices Market, By Product, 2010 - 2018 ($Billion)
Table 8. Global Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 9. Global Self-Injection Devices Market, By Product, 2010 - 2018 ($Billion)
Table 10. Global Self-Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 11. Global Others Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 12. Global Auto Injectors Products Market, By Geography, 2010 - 2018 ($Million)
Table 13. Global Auto Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 14. Global Prefilled Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 15. Global Fillable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 16. Global Auto Injectors Market, By User Intervention, 2010 - 2018 ($Million)
Table 17. Global Automated Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 18. Global Manual Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 19. Global Auto Injectors Market, By Design, 2010 - 2018 ($Million)
Table 20. Global Standardized Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 21. Global Customized Auto Injectors Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 22. Global Auto Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 23. Global Disposable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 24. Global Reusable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 25. Global Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 26. Global Pen Injectors Market, By Product, 2010 - 2018 ($Million)
Table 27. Global Single Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 28. Global Dual Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 29. Global Pen Injectors Market,By Reusability, 2010 - 2018 ($Million)
Table 30. Global Disposable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 31. Global Reusable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 32. Global Pen Injectors Market, By Design, 2010 - 2018 ($Million)
Table 33. Global Standard Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 34. Global Customized Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 35. Global Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 36. Global Needle Free Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 37. Global Prefilled Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 38. Global Fillable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 39. Global Needle Free Injectors Market, By Technology, 2010 - 2018 ($Million)
Table 40. Global Jet-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 41. Global Spring-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 42. Global Laser-Powered Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 43. Global Vibration-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 44. Global Needle Free Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 45. Global Disposable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 46. Global Reusable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 47. Global Conventional Injection Devices Market, By Reusability, 2010 - 2018 ($Billion)
Table 48. Global Disposable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 49. Global Reusable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 50. Global Conventional Injection Devices Market, By Material, 2010 - 2018 ($Billion)
Table 51. Global Glass Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 52. Global Plastics Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 53. Global Conventional Injection Devices Market, By Drug Loading, 2010 - 2018 ($Billion)
Table 54. Global Prefilled Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 55. Global Fillable Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 56. Global Injectable Drug Delivery Market, By Formulation Delivery Types, 2010 - 2018 ($Billion)
Table 57. Global Injectable Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 58. Global Conventional Drug Delivery Formulations Market, By Dosage Form, 2010 – 2018 ($Billion)
Table 59. Global Conventional Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 60. Global Injectable Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 61. Global Reconstituted Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 62. Global Novel Drug Delivery Formulations Market, By Delivery Systems, 2010 - 2018 ($Billion)
Table 63. Global Novel Drug Delivery Formulation Solutions Market, By Geography, 2010 - 2018 ($Billion)
Table 64. Global Liposomal Systems Based Drug Delivery Formulations, By Geography, 2010 - 2018 ($Million)
Table 65. Global Microspheres Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 66. Global Nanoparticles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 67. Global Polymeric Micelles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 68. Other Novel Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 69. Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications, 2010 - 2018 ($Million)
Table 70. Global Auto-Immune Therapeutic Market, By Indication, 2010 - 2018 ($Million)
Table 71. Global Auto-Immune Therapeutic Market, By Geography, 2010 - 2018 ($Million)
Table 72. Global Multiple Sclerosis Market, By Geography, 2010 - 2018 ($Million)
Table 73. Global Rheumatoid Arthritis Market, By Geography, 2010 - 2018 ($Million)
Table 74. Global Crohn's Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 75. Global Psoriasis Market, By Geography, 2010 - 2018 ($Million)
Table 76. Other Auto-Immune Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 77. Global Hormonal Disorder Therapeutics Market, By Indication, 2010 - 2018 ($Million)
Table 78. Global Hormonal Disorders Therapeutics Market, By Geography, 2010 – 2018 ($Billion)
Table 79. Global Diabetes Therapeutics Market, By Geography, 2010 - 2018 ($Billion)
Table 80. Global Anemia Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 81. Global Reproductive Health Diseases Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 82. Globalosteoporosis Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 83. Global Growth Hormone Deficiency Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 84. Global Antithrombotic Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 85. Global Orphan/Rare Diseases Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 86. Global Oncology Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 87. Global Other Therapeutics Market, 2010 - 2018 ($Million)
Table 88. Global Other Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 89. Global Pain Management Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 90. Global Hepatitis C Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 91. Global Allergies Therapeutics Market, By Geography 2010 - 2018 ($Million)
Table 92. Global Aesthetic Treatment Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 93. North America Injectable Drug Delivery Technologies Market,2010 - 2018 ($Billion)
Table 94. North America Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Billion)
Table 95. North America Injectable Drug Delivery Formulation Solutions Market, 2010 - 2018 ($Billion)
Table 96. North America Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 97. Europe Injectable Drug Delivery Technologies Market, 2010 - 2018 ($Billion)
Table 98. Europe Injectable Drug Delivery Devices Market, 2010 - 2018 ($Million)
Table 99. Europe Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 100. Europe Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 101. Asia Pacific Injectable Drug Delivery Technologies Market, By Segment,2010 - 2018 ($Billion)
Table 102. Asia Pacific Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 103. Asia Pacific Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 104. Asia Pacific Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 105. Rest of World Injectable Drug Delivery Technologies Market, By Segment, 2010 - 2018 ($Million)
Table 106. Rest of World Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 107. Rest of World Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Million)
Table 108. Rest of World Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 109. Alkermes: Total Revenue and R&D Expenses,2011– 2013 ($Million)
Table 110. Alkermes: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 111. Antares Pharma: Total Revenue and R&D Expenses,2010– 2012 ($Million)
Table 112. Antares Pharma: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 113. Antares Pharma: Total Revenue, By Product,2010 – 2012 ($Million)
Table 114. Baxter International: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 115. Baxter International: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 116. Baxter International: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 117. Baxter International: Medical Products Total Revenue, 2010 – 2012($Million)
Table 118. Becton Dickinson: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 119. Becton Dickinson: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 120. Becton Dickinson: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 121. Becton Dickinson: Medical Divsion Total Revenue,  2010 – 2012($Million)
Table 122. Consort Medical: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 123. Consort Medical: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 124. Eli Lilly & Co: Total Revenue and R&D Expenses,2010– 2012 ($Billion)
Table 125. Eli Lilly & Co: Total Revenue, By Geography,2010 – 2012 ($Billion)
Table 126. Eli Lilly & Co: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 127. Gerresheimer Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 128. Gerresheimer Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 129. Gerresheimer Ag: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 130. Novo Nordisk: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 131. Novo Nordisk: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 132. Novo Nordisk: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 133. Sanofi: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 134. Sanofi: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 135. Sanofi: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 136. Schott Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 137. Schott Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 138. Terumo Corporation: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 139. Terumo Corporation: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 140. Terumo Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 141. Unilife Corporation: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 142. Unilife Corporation: Total Revenue, By Segment, 2011 – 2013 ($Million)
Table 143. West Pharma: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 144. West Pharma: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 145. West Pharma: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 146. Ypsomed: Total Revenue and R&D Expenses, 2011– 2012 ($Million)
Table 147. Ypsomed: Total Revenue, By Geography, 2011-2012 ($Million)
Table 148. Ypsomed: Total Revenue, By Segment, 2011 – 2012 ($Million)
Table 149. Zogenix, Inc.: Total Revenue and R&D Expenses, 2010– 2012 ($Million)

 
List of Figures:

Figure 1. Drug Injection Devices Segmentation
Figure 2. Drug Injection Formulations Segmentation
Figure 3. Drug Injection Formulations Segmentation
Figure 4. Global Conventional Injection Devices Market Share Analysis (%), 2012
Figure 5. Global Self-Injection Devices Market Share Analysis (%), 2012
Figure 6. Global Auto Injector Devices Market Share Analysis (%), 2012
Figure 7. Global Pen Injector Devices Market Share Analysis (%), 2012
Figure 8. Global Needle Free Injector Devices Market Share Analysis (%), 2012
Figure 9. Global Diabetes Market, By Treatment Methods (%), 2012 and 2018
Figure 10. Injectable Drug Delivery Devices, Value Chain Analysis
Figure 11. Drug Delivery Injection Devices – Product Segmentation
Figure 12. Global Injectable Drug Delivery Market, By Geography, 2013 (%)
Figure 13. Global IDD Market M&A's, Collaborations, Jv's & Partnerships, By Company (2013)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports